nach oben

Obesity Surgery

Erschienen in:

02.10.2021 | Original Contributions

Gastroesophageal Reflux Disease, Esophagitis, and Barrett’s Esophagus 3 to 4 Years Post Sleeve Gastrectomy

verfasst von: Samer Elkassem

Erschienen in: Obesity Surgery | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Sleeve gastrectomy (SG) has become the most popular bariatric procedure worldwide. However, SG is associated with de novo gastroesophageal reflux (GERD) and esophagitis, with concerns for progression into Barrett’s esophagus (BE). The purpose of this study is to assess the clinical and endoscopic progression of GERD, esophagitis, and BE 3 to 4 years after SG.

Methods

Fifty-eight patients (pts) were assessed with endoscopy preoperative and at 3 to 4 years post SG, representing 44.9% follow-up. Endoscopy was offered to all SG pts regardless of symptoms. Outcomes including percent total weight loss (%TWL), PPI use, esophagitis progression, de novo reflux, and BE formation.

Results

At post-op follow-up, the %TWL was 23%. The average BMI dropped from 49.07 to 37.5. De novo reflux developed in 13 pts (30.9%). Of the 16 pts with GERD pre-op, 37.5% improved, 25% had stable disease, and 37.5% had worsening symptoms. The rate of esophagitis nearly doubled from 37.9% pre-op to 70.6% post-op. A majority of post-op pts had mild esophagitis (87.8%), with 12.1% with LA classes C and D. Asymptomatic esophagitis was found in 68.2% of post-op pts. The incidence of BE was 12.7% post-op, with de novo BE developing in 4 pts, representing 7.2%.

Conclusion

SG is associated with increased rates of asymptomatic esophagitis and de novo reflux at 3 to 4 years post-op. De novo BE was detected as well, highlighting the importance of post-op screening. The majority of pts with GERD pre-op have stable disease or improve.

Graphical abstract

Angrisani L, et al. IFSO Worldwide Survey 2016: Primary, endoluminal, and revisional procedures. Obes Surg. 2018;28(12):3783–94. https://doi.org/10.1007/s11695-018-3450-2.CrossRefPubMed

English WJ, et al. American Society for Metabolic and Bariatric Surgery 2018 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2020;16(4):457–63. https://doi.org/10.1016/j.soard.2019.12.022.CrossRefPubMed

Peterli R, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65. https://doi.org/10.1001/jama.2017.20897.CrossRefPubMedPubMedCentral

Salminen P, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the sleevepass randomized clinical trial. JAMA. 2018;319(3):241–54. https://doi.org/10.1001/jama.2017.20313.CrossRefPubMedPubMedCentral

Osland E, Yunus RM, Khan S, et al. Postoperative early major and minor complications in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review. Obes Surg. 2016;26(10):2273–84. https://doi.org/10.1007/s11695-016-2101-8.CrossRefPubMed

Ali M, Chaar ME, Ghiassi S, et al. American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2017;13(10):1652–7. https://doi.org/10.1016/j.soard.2017.08.007.CrossRefPubMed

Gagner M, Hutchinson C, Rosenthal R. Fifth International Consensus Conference: current status of sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(4):750–6. https://doi.org/10.1016/j.soard.2016.01.022.CrossRefPubMed

Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux? Ann Surg. 2019; Publish Ahead of Print, no. NA, p. NA. https://doi.org/10.1097/sla.0000000000003275

Assalia A, Gagner M, Nedelcu M, et al. Gastroesophageal reflux and laparoscopic sleeve gastrectomy: results of the First International Consensus Conference. Obes Surg. 2020;30(10):3695–705. https://doi.org/10.1007/s11695-020-04749-0.CrossRefPubMed

10.

Soricelli E, Casella G, Baglio G, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(6):751–6. https://doi.org/10.1016/j.soard.2018.02.008.CrossRefPubMed

11.

Sebastianelli L, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of barrett’s esophagus: results of a multicenter study. Obes Surg. 2019;29(5):1462–9. https://doi.org/10.1007/s11695-019-03704-y.CrossRefPubMed

12.

Felsenreich DM, et al. Update: 10 years of sleeve gastrectomy—the first 103 patients. Obes Surg. 2018;28(11):3586–94. https://doi.org/10.1007/s11695-018-3399-1.CrossRefPubMed

13.

Fisher OM, et al. Barrett’s oesophagus and bariatric/metabolic surgery—IFSO 2020 Position Statement. Obes Surg. 2021;1–20. https://doi.org/10.1007/s11695-020-05143-6

14.

Mahawar KK, et al. The first modified Delphi consensus statement on sleeve gastrectomy. Surg Endosc. 2021;1–7. https://doi.org/10.1007/s00464-020-08216-w

15.

Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of barrett’s esophagus. Am J Gastroenterol. 2016;111(1):30–50. https://doi.org/10.1038/ajg.2015.322.CrossRefPubMed

16.

Fitzgerald RC, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7. https://doi.org/10.1136/gutjnl-2013-305372.CrossRefPubMed

17.

Barrie J, Yanni F, Sherif M, et al. Length of Barrett’s esophagus in the presence of low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Surg Endosc. 2021;35(8):4756–62. https://doi.org/10.1007/s00464-020-07950-5.CrossRefPubMed

18.

Parikh M, Issa R, McCrillis A, et al. Surgical strategies that may decrease leak after laparoscopic sleeve gastrectomy. Ann Surg. 2013;257(2):231–7. https://doi.org/10.1097/sla.0b013e31826cc714.CrossRefPubMed

19.

Mandeville Y, et al. Moderating the enthusiasm of sleeve gastrectomy: up to fifty percent of reflux symptoms after ten years in a consecutive series of one hundred laparoscopic sleeve gastrectomies. Obes Surg. 2017;27(7):1797–803. https://doi.org/10.1007/s11695-017-2567-z.CrossRefPubMed

20.

Borbély Y, et al. De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc. 2019;33(3):789–93. https://doi.org/10.1007/s00464-018-6344-4.CrossRefPubMed

21.

Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. Ann Surg. 2014;260(5):909–15. https://doi.org/10.1097/sla.0000000000000967.CrossRefPubMed

22.

Oor JE, Roks DJ, Ünlü Ç, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67. https://doi.org/10.1016/j.amjsurg.2015.05.031.CrossRefPubMed

23.

Braghetto I and Korn O. Late esophagogastric anatomic and functional changes after sleeve gastrectomy and its clinical consequences with regards to gastroesophageal reflux disease. Dis Esophagus. 2019;32(6). https://doi.org/10.1093/dote/doz020

24.

Tai C-M, Huang C-K, Lee Y-C, et al. Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults. Surg Endosc. 2013;27(4):1260–6. https://doi.org/10.1007/s00464-012-2593-9.CrossRefPubMed

25.

Signorini F, Olguín S, Viscido G, et al. Esophagitis evolution after sleeve gastrectomy or gastric bypass in consecutive cases. Surg Endosc. 2020;34(10):4330–5. https://doi.org/10.1007/s00464-019-07199-7.CrossRefPubMed

26.

Qumseya BJ, et al. Barrett’s esophagus after sleeve gastrectomy: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343-352.e2. https://doi.org/10.1016/j.gie.2020.08.008.CrossRefPubMed

27.

Matar R, et al. Esophagitis after bariatric surgery: large cross-sectional assessment of an endoscopic database. Obes Surg. 2020;30(1):161–8. https://doi.org/10.1007/s11695-019-04164-0.CrossRefPubMed

28.

Genco A, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74. https://doi.org/10.1016/j.soard.2016.11.029.CrossRefPubMed

29.

del Genio G, et al. Sleeve gastrectomy and development of ‘de novo’ gastroesophageal reflux. Obes Surg. 2014;24(1):71–7. https://doi.org/10.1007/s11695-013-1046-4.CrossRefPubMed

30.

Gu L, et al. Relationship between bariatric surgery and gastroesophageal reflux disease: a systematic review and meta-analysis. Obes Surg. 2019;29(12):4105–13. https://doi.org/10.1007/s11695-019-04218-3.CrossRefPubMed

31.

Silveira FC, et al. The effect of laparoscopic sleeve gastrectomy on gastroesophageal reflux disease. Obes Surg. 2021;31(3):1139–46. https://doi.org/10.1007/s11695-020-05111-0.CrossRefPubMed

32.

Garay M, et al. Influence of antrum size on gastric emptying and weight-loss outcomes after laparoscopic sleeve gastrectomy (preliminary analysis of a randomized trial). Surg Endosc. 2018;32(6):2739–45. https://doi.org/10.1007/s00464-017-5972-4.CrossRefPubMed

33.

Melissas J, et al. Sleeve gastrectomy — a restrictive procedure? Obes Surg. 2007;17(1):57. https://doi.org/10.1007/s11695-007-9006-5.CrossRefPubMed

34.

Daes J, Jimenez ME, Said N, et al. Improvement of gastroesophageal reflux symptoms after standardized laparoscopic sleeve gastrectomy. Obes Surg. 2014;24(4):536–40. https://doi.org/10.1007/s11695-013-1117-6.CrossRefPubMed

35.

Chang D-M, Lee W-J, Chen J-C, et al. Thirteen-year experience of laparoscopic sleeve gastrectomy: surgical risk, weight loss, and revision procedures. Obes Surg. 2018;28(10):2991–7. https://doi.org/10.1007/s11695-018-3344-3.CrossRefPubMed

36.

Arman GA, Himpens J, Dhaenens J, et al. Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778–86. https://doi.org/10.1016/j.soard.2016.01.013.CrossRefPubMed

37.

Kehagias I, Spyropoulos C, Karamanakos S, et al. Efficacy of sleeve gastrectomy as sole procedure in patients with clinically severe obesity (BMI ≤50 kg/m2). Surg Obes Relat Dis. 2013;9(3):363–9. https://doi.org/10.1016/j.soard.2011.12.011.CrossRefPubMed

38.

Boza C, Daroch D, Barros D, et al. Long-term outcomes of laparoscopic sleeve gastrectomy as a primary bariatric procedure. Surg Obes Relat Dis. 2014;10(6):1129–33. https://doi.org/10.1016/j.soard.2014.03.024.CrossRefPubMed

39.

Barr AC, Frelich MJ, Bosler ME, et al. GERD and acid reduction medication use following gastric bypass and sleeve gastrectomy. Surg Endosc. 2017;31(1):410–5. https://doi.org/10.1007/s00464-016-4989-4.CrossRefPubMed

40.

Daher HB, Sharara AI. Gastroesophageal reflux disease, obesity and laparoscopic sleeve gastrectomy: the burning questions. World J Gastroentero. 2019;25(33):4805–13. https://doi.org/10.3748/wjg.v25.i33.4805.CrossRef

41.

Platt KD, Schulman AR. Screening for Barrett’s esophagus after sleeve gastrectomy. Gastrointest Endosc. 2021;93(2):353–5. https://doi.org/10.1016/j.gie.2020.09.017.CrossRefPubMed

42.

Balla A, et al. Manometric and pH-monitoring changes after laparoscopic sleeve gastrectomy: a systematic review. Langenbeck’s Archives Surg. 2021;1–19. https://doi.org/10.1007/s00423-021-02171-3.

43.

Mion F, et al. High-resolution impedance manometry after sleeve gastrectomy: increased intragastric pressure and reflux are frequent events. Obes Surg. 2016;26(10):2449–56. https://doi.org/10.1007/s11695-016-2127-y.CrossRefPubMed

44.

Lazoura O, et al. Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology. Obes Surg. 2011;21(3):295–9. https://doi.org/10.1007/s11695-010-0339-0.CrossRefPubMed

45.

Berry R, et al. Patterns of abnormal gastric pacemaking after sleeve gastrectomy defined by laparoscopic high-resolution electrical mapping. Obes Surg. 2017;27(8):1929–37. https://doi.org/10.1007/s11695-017-2597-6.CrossRefPubMed

46.

Sioka E, et al. Impact of laparoscopic sleeve gastrectomy on gastrointestinal motility. Gastroent Res Pract. 2018;2018:1–17. https://doi.org/10.1155/2018/4135813.CrossRef

47.

Thereaux J, et al. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors 4 years after surgery? A nationwide cohort. Surg Obes Relat Dis. 2017;13(6):951–9. https://doi.org/10.1016/j.soard.2016.12.013.CrossRefPubMed

48.

Holmberg D, Santoni G, Xie S, et al. Gastric bypass surgery in the treatment of gastro-oesophageal reflux symptoms. Aliment Pharm Therap. 2019;50(2):159–66. https://doi.org/10.1111/apt.15274.CrossRef

49.

Csendes A, Orellana O, Martínez G, et al. Clinical, endoscopic, and histologic findings at the distal esophagus and stomach before and late (10.5 years) after laparoscopic sleeve gastrectomy: results of a prospective study with 93% follow-up. Obes Surg. 2019;29(12):3809–17. https://doi.org/10.1007/s11695-019-04054-5.CrossRefPubMed

50.

Length of Barrettâ€™s oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma

51.

Guda NM, Partington S, Vakil N. Inter- and intra-observer variability in the measurement of length at endoscopy: implications for the measurement of Barrett’s esophagus. Gastrointest Endosc. 2004;59(6):655–8. https://doi.org/10.1016/s0016-5107(04)00182-8.CrossRefPubMed

52.

Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002;122(1):26–33. https://doi.org/10.1053/gast.2002.30297.CrossRefPubMed

53.

Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett’s adenocarcinomas: a population-based study. Gastroenterology. 2002;122(3):633–40. https://doi.org/10.1053/gast.2002.31879.CrossRefPubMed

54.

Vyas M, et al. Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction. Hum Pathol. 2020;105:67–73. https://doi.org/10.1016/j.humpath.2020.08.007.CrossRefPubMed

55.

Felsenreich DM, et al. Roux-en-Y gastric bypass as a treatment for Barrett’s esophagus after sleeve gastrectomy. Obes Surg. 2020;30(4):1273–9. https://doi.org/10.1007/s11695-019-04292-7.CrossRefPubMed

56.

Gagner M. Is sleeve gastrectomy always an absolute contraindication in patients with Barrett’s? Obes Surg. 2016;26(4):715–7. https://doi.org/10.1007/s11695-015-1983-1.CrossRefPubMed

57.

Gyawali CP, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351. https://doi.org/10.1136/gutjnl-2017-314722.CrossRefPubMed

Titel: Gastroesophageal Reflux Disease, Esophagitis, and Barrett’s Esophagus 3 to 4 Years Post Sleeve Gastrectomy
verfasst von: Samer Elkassem
Publikationsdatum: 02.10.2021
Verlag: Springer US
Erschienen in: Obesity Surgery / Ausgabe 12/2021
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-021-05688-0

Neu im Fachgebiet Chirurgie

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Gastroesophageal Reflux Disease, Esophagitis, and Barrett’s Esophagus 3 to 4 Years Post Sleeve Gastrectomy

Abstract

Background

Methods

Results

Conclusion

Graphical abstract

Neu im Fachgebiet Chirurgie

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

Klinikreform soll zehntausende Menschenleben retten

Update Chirurgie

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

S2e-Leitlinie „Distale Radiusfraktur“

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2021

Combined Re-sleeve and Single Anastomosis Sleeve Ileal (SASI) Bypass as a Second Stage After Sleeve Gastrectomy (Video Report)

Tibial Bone Quality in Former Bariatric Surgery Patients with Osteoarthritis

Quality of Life After Bariatric Surgery—a Systematic Review with Bayesian Network Meta-analysis

Occult Splenic Erosion due to a Retained Gastric Clip — a Case Report

Midterm Results from the Dutch Common Channel Trial (DUCATI): Superior Weight Loss Results of the Long Roux Limb Gastric Bypass in Comparison to the Standard Bypass at 3-Year Follow-Up

“What Really Matters When Performing a Laparoscopic Roux-en Y Gastric Bypass?” Literature-Based Key Steps Towards Success and Standardization of the Procedure

Update Chirurgie